Dieticyclidine
Chemical compound
- none
- CA: Schedule I
- UK: Class B
- N,N-diethyl-1-phenylcyclohexan-1-amine
- 2201-19-6
Y
- 604690
- 525655
N
- 8JY6P22UVD
- DTXSID00944617
- Interactive image
- CCN(CC)C1(CCCCC1)C2=CC=CC=C2
InChI
- InChI=1S/C16H25N/c1-3-17(4-2)16(13-9-6-10-14-16)15-11-7-5-8-12-15/h5,7-8,11-12H,3-4,6,9-10,13-14H2,1-2H3N
- Key:GRHWLIMQOFAGHA-UHFFFAOYSA-NN
N
Y (what is this?) (verify)Dieticyclidine (PCDE), or diethylphenylcyclohexylamine, is a psychoactive drug and research chemical of the arylcyclohexylamine chemical class related to phencyclidine (PCP) and eticyclidine (PCE). It acts as an NMDA receptor antagonist but has low potency and acts mainly as a prodrug for eticyclidine.[1][2]
References
- ^ Cho AK, Hiramatsu M, Schmitz DA, Landaw EM, Chang AS, Ramamurthy S, Jenden DJ (1993). "A pharmacokinetic study of phenylcyclohexyldiethylamine. An analog of phencyclidine". Drug Metabolism and Disposition. 21 (1): 125–32. PMID 8095205.
- ^ Cho AK, Hiramatsu M, Schmitz DA, Vargas HM, Landaw EM (March 1993). "A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine". The Journal of Pharmacology and Experimental Therapeutics. 264 (3): 1401–5. PMID 8450474.
- v
- t
- e
| Phenols | |
|---|---|
| Barbiturates | |
| Benzodiazepines | |
| Opioids | |
| Arylcyclohexylamines | |
| Neuroactive steroids | |
| Others |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||
|---|---|---|---|---|---|---|---|
| D1-like |
| ||||||
| D2-like |
| ||||||
| |||||||
| |
|---|---|
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
|
| KARTooltip Kainate receptor |
|
| NMDARTooltip N-Methyl-D-aspartate receptor |
|
| |
 | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
